Archive: Pre-IPO Profits

Premium

The Importance of Co-Investors

By Adam Sharp on July 21, 2020

As online angel investors, there’s an easy metric we can use when judging possible investments. If we pay attention to who else is investing in a startup’s round (also known as co-investors), we can learn a lot about the quality of the deal.  For example, if…
Premium
Over recent months, AngelList has made some major updates to their investor dashboard (if you haven’t been given access to the new dashboard yet, they should be rolling it out to you soon). To access the dashboard, log into Angel.co and…
Premium
Today in America, accredited investors still have a major advantage over non-accredited investors (approximately 92% of America).  We can invest in all private startup and company deals, including those on sites like AngelList. These Regulation D deals have no limit on the amount of money the…
Premium

AngelList Access Funds Show Promise

By Adam Sharp on June 30, 2020

Let’s talk about AngelList Access funds. These funds allow you to make a single investment and get exposure to the hundreds of top startup deals that take place on AngelList. I wrote about them back in January. Now,…
Premium
Traditionally, startup investors (VCs and angels) tended to do deals in person. It’s a slow and inefficient method. But it’s the way things have always been done. During this crisis, everyone has been forced to operate remotely. But from what I’m reading…
Premium

Startup Investing in a Recession

By Adam Sharp on June 16, 2020

The U.S. stock markets are nearing all-time highs. But all is not well with the economy. A huge portion of small businesses are struggling to pay bills. Big corporations are faring better, but they have their own issues that need to be addressed — too much…
Premium

Avoid High-Priced Startup Deals

By Adam Sharp on June 9, 2020

In the last week, I’ve been invited to invest in two hot deals on AngelList. Both companies are doing well because of changes caused by COVID-19. One is in telehealth. The other is in food delivery. But when I checked the valuation on these…
Premium

How to Naturally Diversify Your Portfolio

By Adam Sharp on June 2, 2020

When it comes to startup investing, I am “industry agnostic.” In other words, I never invest in a deal just because it’s in a certain sector. Instead, I evaluate every deal individually. I look at the fundamentals, model, team and growth rate. This approach has naturally…
Premium

How to Cope With a Lack of Startup Updates

By Adam Sharp on May 26, 2020

I was very excited when I first began online angel investing in 2014. I loved the concept. So I invested in 15 deals within just a few months on AngelList and FundersClub. I thought they were high quality picks. And I eagerly waited to see how they would do. But…
Premium

Raise Your Personal Investment Bar

By Adam Sharp on May 19, 2020

As I mentioned last week, there’s been a significant decrease in the number of startup deals coming across my desk lately. On the bright side, though, the quality of deals on accredited sites like AngelList is much higher (on average) than I’ve ever seen. This is a common trend during…
Premium

Startup Deal Flow Changing

By Adam Sharp on May 12, 2020

One of my favorite AngelList syndicate leaders recently wrote a note to all the members of his syndicate. He told us the volume of new deals he’s seeing is down about 90%. Many of the startup deals we’re seeing right now were arranged before the COVID-19 quarantines started. These deals…
Premium

New Syndicate on AngelList

By Adam Sharp on May 5, 2020

Adam Sharp explains why he joined a new syndicate on AngelList.
Premium

How My Startups Are Holding Up

By Adam Sharp on April 28, 2020

Adam Sharp takes a look at how his startup portfolio is performing during the COVID-19 pandemic.
Premium
COVID-19 has disrupted life as we know it. And when we emerge from this crisis, there will be a new economic normal. Adam Sharp looks at what will change.
Premium
As the COVID-19 pandemic continues, early-stage deals look pretty much the same so far. What’s up with that?